Cytosorbents Corporation (CTSO) vs SINTX TECHNOLOGIES, INC. (SINT)
- Cytosorbents Corporation CTSO 4.11 +34.31%
- SINTX TECHNOLOGIES, INC. SINT 1.74 −1.69%
Cytosorbents Corporation and SINTX TECHNOLOGIES, INC. are both Medical Devices companies. SINTX TECHNOLOGIES, INC. is the larger, with a market value of $13.4M against $9.7M — 1.4× the size. Cytosorbents Corporation grew revenue faster over the last twelve months: 3.07% against −28.5%. Cytosorbents Corporation has the higher net margin (−48.9% vs −1,423.0%) and the higher return on invested capital (−66.9% vs −548.1%). Across the 17 metrics below, Cytosorbents Corporation leads on 15 and SINTX TECHNOLOGIES, INC. on 2.
Valuation
Profitability
| Metric | CTSO | SINT | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.61% | 52.86% | 56.01% |
| Operating margin | (34.74%) | (884.81%) | (15.03%) |
| Net margin | (48.94%) | (1,423.01%) | (20.40%) |
| Free cash flow margin | (25.32%) | (777.14%) | (7.24%) |
| Return on equity | (336.17%) | (429.26%) | (15.32%) |
| Return on assets | (42.38%) | (192.88%) | (19.72%) |
| Return on invested capital | (66.90%) | (548.06%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack